Corvel Corp SEC Filings

CorVel Corp (CRVL) executive vice president for Risk Management Services, Mark Bertels, reported an insider transaction involving company stock. On 11/19/2025, he exercised a non-qualified stock option to buy 1,200 shares of common stock at an exercise price of $34.437 per share, then sold 1,200 shares of common stock at a price of $72.35 per share on the same date. After these transactions, he directly owns 2,594 shares of CorVel common stock and holds no remaining derivative securities from this option grant. The option was originally structured to vest 25% one year after grant with the balance vesting in 36 equal monthly installments.

CorVel (CRVL) director reported open‑market sales on a Form 4. On 11/10/2025, 210 shares of common stock were sold at $76.27, leaving 122,121 shares beneficially owned directly. On 11/11/2025, a further 7,076 shares were sold at $76.94, bringing direct beneficial ownership to 115,045 shares.

The filing indicates a single reporting person and direct ownership of all reported holdings.

CorVel Corp (CRVL) reported a Form 4 for Vice President of Accounting Jennifer Yoss. On 11/06/2025, she was granted 3,500 non‑qualified stock options with an exercise price of $75.36, expiring on 11/06/2030.

The options will vest based on achievement of performance criteria relating to earnings growth. Following the grant, she beneficially owned 3,500 derivative securities held directly.

CorVel Corp (CRVL) disclosed that Chief Information Officer Maxim Shishin received a performance-based non-qualified stock option grant. The award covers 4,000 options with an exercise price of $75.36, granted on 11/06/2025 and expiring on 11/06/2030. Vesting is tied to achieving certain performance criteria relating to earnings growth. The filing lists the ownership of the derivative securities as direct.

CorVel (CRVL) reported an insider equity grant. The company’s EVP of Risk Management Services received a non-qualified stock option for 4,000 shares at an exercise price of $75.36 on 11/06/2025, coded “A” for award. The option expires on 11/06/2030 and vests based on achieving performance criteria related to earnings growth. Following the grant, 4,000 derivative securities were beneficially owned, held directly.

CorVel Corporation filed a Form S-8 registering 1,775,459 shares of common stock for issuance under the CorVel Corporation 2025 Stock Incentive Plan. The plan was approved by stockholders on August 7, 2025. This registration supports equity-based compensation, allowing the company to grant options and other awards to employees, directors, and eligible participants under the plan.

Form S-8 registrations are administrative and do not, by themselves, represent a capital raise or a public sale. Instead, they make plan shares available for future grants consistent with the plan’s terms and applicable securities laws.

CorVel Corporation reported stronger quarterly results for the three months ended September 30, 2025. Revenue reached $239,643,000, up 7% year over year, as network solutions activity expanded with existing customers. Net income was $27,906,000 and diluted EPS was $0.54, compared with $0.45 a year ago.

Profitability improved: gross margin rose to 24.3% from 22.6%, while general and administrative costs held near 9% of revenue. Segment mix was 62.9% patient management ($150,795,000) and 37.1% network solutions ($88,848,000). Operating cash flow for the first six months totaled $80,035,000, supporting cash and equivalents of $207,453,000.

The company continued buybacks, repurchasing 143,774 shares for approximately $12.8 million in the quarter and 230,879 shares for $22.5 million year-to-date. Shares outstanding were 51,293,374 as of September 30, 2025. Management also noted a recent technology asset acquisition to enhance bill review capabilities.

CorVel Corporation issued a press release announcing its financial results for the three and six months ended September 30, 2025, and furnished it as Exhibit 99.1.

The information was furnished to the SEC and is not deemed filed under the Exchange Act. CorVel’s common stock (CRVL) is listed on the Nasdaq Global Select Market.

Jennifer Yoss, Vice President of Accounting at CorVel Corp (CRVL), reported a purchase of 35 shares of CorVel common stock on 09/30/2025 at a price of $73.549 per share. The shares were acquired under the issuer's Employee Stock Purchase Plan in a transaction exempt under SEC Rule 16b-3(c). Following the purchase, Ms. Yoss beneficially owns 2,123 shares, held directly. The Form 4 was signed on behalf of the reporting person by Sharon O'Connor on 10/01/2025.